...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM

KOO - If BoM2 fails, the debt might not be repaid but the RPS's are probably worthless also. If the current debt is paid off which has the IP as security, the IP might then be used for the Zenith loan. In that case, if RVX defaulted, the loan wouldn't be repaid but Zenith would then have the RVX IP.

3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM
3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply